Bing‐Mae Chen
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Biomaterials 18
- Nanoparticle-Based Drug Delivery 18
- Immunology 20
- Toxin Mechanisms and Immunotoxins 8
- Biosimilars and Bioanalytical Methods 5
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 4
- Co-authors
- Steve R. Roffler (46 shared papers)Tian‐Lu Cheng (25 shared papers)Yu-Cheng Su (12 shared papers)Pierre‐Alain Burnouf (5 shared papers)André Lieber (2 shared papers)Yechezekel Barenholz (2 shared papers)Kuo‐Hsiang Chuang (4 shared papers)Chien-Hsiun Chen (2 shared papers)
- Journals
- Bioconjugate Chemistry (7 papers)ACS Nano (5 papers)Journal of Controlled Release (4 papers)PLoS ONE (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- TaiwanUnited StatesIsrael
In The Last Decade
Bing‐Mae Chen
46 papers receiving 2.4k citations
Bing‐Mae Chen's Hit Papers
Peers
Comparison fields: 5 of 93
- Biomaterials 1k
- Immunology 447
- Pharmaceutical Science 116
- Surfaces, Coatings and Films 105
- Radiology, Nuclear Medicine and Imaging 320
Countries citing papers authored by Bing‐Mae Chen
This map shows the geographic impact of Bing‐Mae Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Mae Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Mae Chen more than expected).
Fields of papers citing papers by Bing‐Mae Chen
This network shows the impact of papers produced by Bing‐Mae Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Mae Chen. The network helps show where Bing‐Mae Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Mae Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies Hit paper breakdown → | 2021 | 465 |
| 2 | 2016 | 212 | |
| 3 | 2010 | 181 | |
| 4 | 2020 | 113 | |
| 5 | 2012 | 110 | |
| 6 | 2018 | 100 | |
| 7 | 2005 | 82 | |
| 8 | 2010 | 82 | |
| 9 | 2007 | 79 | |
| 10 | Tumor-associated antigen L6 and the invasion of human lung cancer cells. | 2003 | 75 |
| 11 | 2017 | 72 | |
| 12 | 2023 | 71 | |
| 13 | 2023 | 71 | |
| 14 | 2000 | 60 | |
| 15 | 2017 | 57 | |
| 16 | 2014 | 52 | |
| 17 | 1997 | 46 | |
| 18 | 2016 | 39 | |
| 19 | 2021 | 37 | |
| 20 | 2010 | 33 |
About Bing‐Mae Chen
Bing‐Mae Chen is a scholar working on Biomaterials, Immunology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Hematology, having authored 46 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (18 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Toxin Mechanisms and Immunotoxins (8 papers), Biosimilars and Bioanalytical Methods (5 papers), T-cell and B-cell Immunology (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Research and Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biomaterials (1k citations), Immunology (447 citations), Pharmaceutical Science (116 citations), Surfaces, Coatings and Films (105 citations) and Radiology, Nuclear Medicine and Imaging (320 citations). Bing‐Mae Chen has collaborated with scholars based in Taiwan, United States and Israel. Frequent co-authors include Steve R. Roffler, Tian‐Lu Cheng, Yu-Cheng Su, Pierre‐Alain Burnouf, André Lieber, Yechezekel Barenholz, Kuo‐Hsiang Chuang, Chien-Hsiun Chen, Yuan-Tsong Chen and Ji‐Wang Chern. Their work appears in journals such as Bioconjugate Chemistry, ACS Nano, Journal of Controlled Release, PLoS ONE and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.